ASR Vermogensbeheer’s AbbVie ABBV Stock Holding History

ASR Vermogensbeheer’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$48.8M	Buy	194,041 +7,895	+4%	+$1.7M	0.5%	35
2026 Q1	$40.5M	Buy	186,146 +3,284	+2%	+$728K	0.48%	33
2025 Q4	$41.8M	Buy	182,862 +2,038	+1%	+$464K	0.49%	35
2025 Q3	$41.9M	Sell	180,824 -695	-0.4%	-$142K	0.51%	34
2025 Q2	$33.7M	Sell	181,519 -83	-0%	-$15.4K	0.44%	47
2025 Q1	$38.1M	Buy	+181,602	New	+$35.3M	0.56%	34

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ASR Vermogensbeheer's ABBV Position: Q2 2026 in Review

ASR Vermogensbeheer increased its AbbVie (ABBV) stake by 4.2% in Q2 2026, buying an estimated $1.7M and bringing the position to 194,041 shares worth $48.8M. The position accounts for 0.5% of the portfolio, ranked #35.

ASR Vermogensbeheer first reported a position in ABBV in Q1 2025 and has held it in 6 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

ASR Vermogensbeheer held 194,041 shares of AbbVie worth $48.8M as of Q2 2026.
ASR Vermogensbeheer bought 7,895 AbbVie shares in Q2 2026, an estimated $1.7M.
AbbVie made up 0.5% of ASR Vermogensbeheer's portfolio in Q2 2026, its #35 holding.
ASR Vermogensbeheer first reported a position in AbbVie in Q1 2025 and has held it in 6 quarters since.
2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on ASR Vermogensbeheer's 13F filing for Q2 2026, filed 20 Jul 2026.